SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE551.4577.35 (+16.32 %)
PREV CLOSE ( ) 474.10
OPEN PRICE ( ) 468.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 338258
TODAY'S LOW / HIGH ( )461.40 563.75
52 WK LOW / HIGH ( )287 507.2
NSE551.7577.95 (+16.45 %)
PREV CLOSE( ) 473.80
OPEN PRICE ( ) 470.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 551.75 (10312)
VOLUME 6454379
TODAY'S LOW / HIGH( ) 461.25 559.80
52 WK LOW / HIGH ( )286 506.5
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax-448.20-911.002215.001149.10577.50
Adjustment1867.901809.601731.601680.301482.60
Changes In working Capital7.40-3137.90-2058.40-164.50-252.90
Cash Flow after changes in Working Capital1427.10-2239.301888.202664.901807.20
Cash Flow from Operating Activities1562.50-2420.301554.602421.501663.30
Cash Flow from Investing Activities-811.40-2428.50-1063.00-3588.10-1156.90
Cash Flow from Financing Activities-1127.603335.70924.90969.80-233.90
Net Cash Inflow / Outflow-376.50-1513.101416.50-196.80272.50
Opening Cash & Cash Equivalents463.801976.90560.40757.20459.50
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANA25.20
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent87.30463.801976.90560.40757.20

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.